Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT07749014Phase 2Not Yet Recruiting
Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients
Acute Myocardial Infarction (AMI)Coronary Artery DiseaseST-elevation Myocardial Infarction (STEMI)
Studydirector

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Miqdad A Khan, MD, FACC, FISCI, FSCAI, FACP

Rehman Medical Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Acute Myocardial Infarction (AMI)Coronary Artery DiseaseST-Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Michigan State UniversityRehman Medical Institute - RMI
Collaborated on 1 trial
Similarity Score34%

Herbert D Aronow, MD, MPH, MSCAI, FACC, MSVM

Michigan State University College of Human Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Acute Myocardial Infarction (AMI)Coronary Artery DiseaseST-Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Michigan State UniversityRehman Medical Institute - RMI
Collaborated on 1 trial
Similarity Score34%

Jiyan Chen, M.D.

Guangdong Provincial People's Hospital

Related
4 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score10%

Amir Lerman, MD

Mayo Clinic

Related
15 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score10%

Zesheng Xu, M.D.

Cangzhou Central Hospital

Related
2 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score10%

Shubin Qiao, M.D.

Chinese Academy of Medical Sciences, Fuwai Hospital

Related
2 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score10%

Christelle Haziza, PhD

Philip Morris Products S.A.

Related
27 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score10%

Hyo-soo Kim, MD, PhD

Seoul National University Hospital

Related
12 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score10%

Jianan Wang, M.D.

The Second Affiliated Hospital of Zhejiang University School of Medical College

Related
2 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score10%

Ron Waksman, MD

Medstar Health Research Institute

Related
18 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07749014Phase 2StudyDirector

Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients

Acute Myocardial Infarction (AMI)Coronary Artery DiseaseST-elevation Myocardial Infarction (STEMI)
Not Yet Recruiting

All 1 trials loaded